Tumor Cell Invasion in Glioblastoma

Abstract

Glioblastoma (GBM) is a particularly devastating tumor with a median survival of about 16 months. Recent research has revealed novel insights into the outstanding heterogeneity of this type of brain cancer. However, all GBM subtypes share the hallmark feature of aggressive invasion into the surrounding tissue. Invasive glioblastoma cells escape surgery and focal therapies and thus represent a major obstacle for curative therapy. This review aims to provide a comprehensive understanding of glioma invasion mechanisms with respect to tumor-cell-intrinsic properties as well as cues provided by the microenvironment. We discuss genetic programs that may influence the dissemination and plasticity of GBM cells as well as their different invasion patterns. We also review how tumor cells shape their microenvironment and how, vice versa, components of the extracellular matrix and factors from non-neoplastic cells influence tumor cell motility. We further discuss different research platforms for modeling invasion. Finally, we highlight the importance of accounting for the complex interplay between tumor cell invasion and treatment resistance in glioblastoma when considering new therapeutic approaches.

Bioinformatics and Molecular Insights to Anti-Metastasis Activity of Triethylene Glycol Derivatives

“…Cancer, a highly complex disease of cell proliferation, is regulated by multiple genes and its micro-environment. Some of the most commonly attributed mechanisms include (i) activation of proto-oncogenes, (ii) inhibition of tumor suppressors, (iii) attainment of autonomous growth signals and resistance to extra-cellular growth-inhibitory signals, (iv) resistance to apoptosis, (v) telomere maintenance and (vi) stimulation of cell migration and neoangiogenesis [1][2][3][4][5][6]. The latter is the prime feature of advanced tumors and primarily involved in the spread of the disease.…”

MicroRNA‑138 modulates glioma cell growth, apoptosis and invasion through the suppression of the AKT/mTOR signalling pathway by targeting CREB1

“…A hallmark of malignant glioma cells is their highly invasive nature ( 37 ). The disruption of the extracellular matrix (ECM) has been identified as an initial step in the penetration of glioma cells into adjacent normal brain tissue ( 38 ).…”

<p>Genetic and Clinical Characterization of HOXB2 in Glioma</p>

“…15,28 It is a complex biological process with multifactor and multicell involvement, including ECM degradation, epithelial-mesenchymal transition, and neovascularization. 29,30 ECM components are large molecules that are synthesized by cells, secreted to the outside of the cells, and become distributed on the surface of the cells or between cells. The components form a complex grid structure that supports and connects the tissue structure and regulates the tissue.…”